Alcobra to Be First Israeli Nasdaq IPO of 2013

Following voided acquisition deal by Teva, firm seeks American investors to fund clinical trials for its ADHD drug.

Yoram Gabison
Send in e-mailSend in e-mail
Yoram Gabison

Comments